Key result
Secondary prevention medications post-CABG, such as aspirin and statins, are essential, while evidence for other agents like clopidogrel, beta-blockers, and ACE inhibitors remains less convincing.
Why the study?
Post-CABG patients have distinct medication needs from general cardiovascular patients, and an unmet need remains for robust population-specific evidence to support current guideline-recommended regimens.
What is the evidence for secondary prevention medications in post-CABG patients?
Population
Post coronary artery bypass graft (CABG) surgery patients
Design
Literature review
Authors
Loading...
Confirms aspirin and statins as essential post-CABG; leaves open convincing evidence for other agents without dedicated trials.
What is the evidence for secondary prevention medications in post-CABG patients?
This review highlights that post-CABG patients have unique secondary prevention needs, with strong evidence for aspirin and statins but a need for more population-specific data for other agents.
Dimitriadis et al. (2021) conducted a review in Post coronary artery bypass grafting (CABG). Secondary prevention medications was evaluated. Secondary prevention medications post-CABG, such as aspirin and statins, are essential, while evidence for other agents like clopidogrel, beta-blockers, and ACE inhibitors remains less convincing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: